These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24754084)

  • 1. [Recent advances in our understanding of the molecular mechanisms of liver fibrosis].
    Tu C; Wang J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):5-8. PubMed ID: 24754084
    [No Abstract]   [Full Text] [Related]  

  • 2. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.
    Bian EB; Zhao B; Huang C; Wang H; Meng XM; Wu BM; Ma TT; Zhang L; Lv XW; Li J
    Cell Signal; 2013 Sep; 25(9):1837-44. PubMed ID: 23707524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic studies in Indian childhood cirrhosis.
    Verma IC; Ghai OP; Chawla V
    Indian J Pediatr; 1971 Mar; 38(278):125-7. PubMed ID: 5124007
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of liver fibrosis.
    Tsukada S; Parsons CJ; Rippe RA
    Clin Chim Acta; 2006 Feb; 364(1-2):33-60. PubMed ID: 16139830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
    Krawczyk M; Grünhage F; Zimmer V; Lammert F
    J Hepatol; 2011 Aug; 55(2):299-306. PubMed ID: 21168459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
    Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
    Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans.
    Weber S; Gressner OA; Hall R; Grünhage F; Lammert F
    Clin Liver Dis; 2008 Nov; 12(4):747-57, vii. PubMed ID: 18984464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis and chronic viral hepatitis.
    Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
    Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomere involvement.
    Carulli L; Dei Cas A; Nascimbeni F
    Hepatology; 2012 Nov; 56(5):2001-3. PubMed ID: 23045155
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic fibrosis -- overview.
    Friedman SL
    Toxicology; 2008 Dec; 254(3):120-9. PubMed ID: 18662740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Marcolongo M; Young B; Dal Pero F; Fattovich G; Peraro L; Guido M; Sebastiani G; Palù G; Alberti A
    Hepatology; 2009 Oct; 50(4):1038-44. PubMed ID: 19676127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Pradat P; Trepo E; Potthoff A; Bakshi R; Young B; Trepo C; Lagier R; Moreno C; Lemmers A; Gustot T; Degre D; Adler M; Wedemeyer H
    Hepatology; 2010 Jan; 51(1):356-7. PubMed ID: 19824080
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver fibrosis in arginase deficiency.
    Jordá A; Portolés M; Rubio V; Capdevila A; Vilas J; García-Piño J
    Arch Pathol Lab Med; 1987 Aug; 111(8):691-2. PubMed ID: 3632278
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype.
    Kawada N
    Methods Mol Med; 2005; 117():371-9. PubMed ID: 16118463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A molecular genetic analysis in 2 children with congenital hepatic fibrosis].
    Harris PR; Cavagnaro S M F
    Rev Med Chil; 2008 Jun; 136(6):815-6. PubMed ID: 18769842
    [No Abstract]   [Full Text] [Related]  

  • 18. Cirrhosis and constitutional telomerase mutations.
    Hiriart JB; Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):607-9. PubMed ID: 21978439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic fibrosis: physiopathology and biological diagnosis].
    Housset C; Guéchot J
    Pathol Biol (Paris); 1999 Nov; 47(9):886-94. PubMed ID: 10609268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
    Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
    J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.